• Urine test developed to diagnose subclinical kidney transplant rejection europeanpharmaceuticalreview
    March 09, 2021
    The novel, non-invasive test detects a rejection signature within mRNA isolated from urine and could, with further development, be used instead of biopsies to identify transplant rejection.
  • Exosomes promote remarkable recovery in stroke worldpharmanews
    January 15, 2020
    It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
  • PureTech lifted by news of Roche deal pharmatimes
    July 23, 2018
    Shares in UK-based clinical-stage biopharm PureTech Health have been given a boost by news that Roche has signed up to advance its exosome platform technology in a deal potentially worth more than $1 billion.
PharmaSources Customer Service